Tariffs on Indian generics could raise US drug prices, disrupt supply chains, and strain insurance systems. Indian firms, ...

The Scheme of Arrangement was approved by the New Delhi Bench of the NCLT under the provisions of the Companies Act, 2013.

Earlier in February, the New Delhi bench of the National Company Law Tribunal (NCLT) approved the amalgamation of Shree Jee ...

The move follows the approval from the National Company Law Tribunal (NCLT), New Delhi Bench. With this consolidation, the ...

Mankind Pharma has received a ₹183.11 crore tax demand from the Income Tax Department for AY 2014-15 to 2017-18 due to ...

The benchmark BSE Sensex slipped 0.25% to close at 77,414, while the broader NSE Nifty 50 fell 0.41% to 23,494, weighed down ...

IST, the barometer index, the S&P BSE Sensex, slipped 259.73 points or 0.34% to 77,348.12. The Nifty 50 index declined 66.35 points, or 0.28%, to 23,525.60.

AM(IST)on Friday in a weak market. J B Chemicals & Pharmaceuticals Ltd.(up 1.35 per cent), Glenmark Pharmaceuticals Ltd.(up 1 ...

Discover an intriguing stock idea with Mankind Pharma showing signs of a rebound and potential upside in price action.

U.S. President Trump imposes 25% tariff on auto imports, spotlight on pharma imports, Indian industry at risk.

Trump had earlier said on March 24 that he will announce tariffs on automobiles, pharmaceuticals and aluminum in the near ...

The Nifty Pharma index closed on a negative note on Wednesday. Shares of Mankind Pharma Ltd.(up 0.24 per cent), Biocon ...